C. Sol dos Reis
YOU?
Author Swipe
View article: P1336: ANTIVIRAL EXPOSURE TO GANCICLOVIR AND VALGANCICLOVIR IS NOT ASSOCIATED WITH INCREASED INCIDENCE OF RELAPSE OR SECONDARY MALIGNANCIES IN HEMATOPOIETIC STEM CELL TRANSPLANTATION RECIPIENTS
P1336: ANTIVIRAL EXPOSURE TO GANCICLOVIR AND VALGANCICLOVIR IS NOT ASSOCIATED WITH INCREASED INCIDENCE OF RELAPSE OR SECONDARY MALIGNANCIES IN HEMATOPOIETIC STEM CELL TRANSPLANTATION RECIPIENTS Open
Background: Hematopoietic stem cell (HSC) transplantation (HSCT) is used in the treatment of hematologic malignancies, bone marrow failure and immunodeficiencies and is often associated with cytomegalovirus (CMV) reactivation/infection. Ga…